New York, USA – October 11, 2022 – Neural tissue damage in the peripheral nervous system (PNS) and central nervous system (CNS) may result in multiple neurological diseases and even life-long disabilities. It has been a major challenge for scientists to cure complex disorders that involve the nervous system. In recent years, neural tissue engineering has been considered a promising strategy for neural repair and neurological disease treatment. Hereinafter, Creative Biolabs encourages scientists to develop proper preclinical models that mimic micro-environments and is dedicated to providing the STEMOD™ neuroscience ex vivo models for clients worldwide.
These two following modeling services at Creative Biolabs will be introduced in more detail:
* Blood-Brain Barrier Models
* Central Nervous System (CNS) Disease Modeling
Science was driven by technological advancements that, once translated to the clinic, fostered new treatments and interventions. Meanwhile, technology-driven medical progress has often outpaced laboratory research, such as the blood-brain barrier models (BBB), one of the tissue structures to be scaled down on a chip.
Creative Biolabs provides various BBB models to meet client needs, including but not limited to:
* Cell-based In Vitro BBB Models
* ECM In Vitro BBB Models
* In Vitro BBB Models based on Microfluidics
* In Vitro BBB Models based on 3D Printing
In addition, Creative Biolabs provides CNS disease modeling services to accelerate the investigation of nervous system disease mechanisms and contribute to the development of novel therapies.
CNS diseases and injuries remain some of the most challenging medical problems to date, such as Alzheimer’s disease (AD), Huntington’s disease (HD), and Parkinson’s disease (PD). Therefore, developing an in vitro model of the central nervous system is of great importance for current research.
“Current traditional in vitro models are limited due to the lack of ability to mimic in vivo functions,” a scientist at Creative Biolabs said, “and the limitations of these models result in low success rates for drug development targeting the central nervous system. In the past five years, surprisingly, in vitro models of the central nervous system have taken a giant leap in complexity and functionality, promising to overcome many limitations of traditional models.”
Therefore, Creative Biolabs has developed a set of custom CNS disease modeling services to support researcher studies, including but not limited to Alzheimer’s disease models, Huntington’s disease models, and Parkinson’s disease models.
To learn more about the neuroscience ex vivo models at Creative Biolabs, please visit https://neurost.creative-biolabs.com.
About Creative Biolabs
With years of experience in developing neuroscience ex vivo models, scientists at Creative Biolabs are committed to providing services for neuroscience research and drug discovery.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://neurost.creative-biolabs.com
